• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

(470) 785-4616

REQUEST AN APPOINTMENT BILL PAY PHYSICIAN REFERRAL REQUEST

  • About Us
    • Blog
  • What to Expect
  • Infusions
  • Conditions
    • Crohn’s Disease
    • Ulcerative Colitis
    • Psoriasis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Testimonials
  • Contact Us
  • Locations
    • Marietta
    • Atlanta (Main)
    • Alpharetta
    • Lawrenceville
    • Watkinsville
Stethoscope and paper with the words Crohn's disease

What Is Infliximab Used for in Autoimmune Conditions?

November 6, 2026

Infliximab (Remicade) is a specialized biologic medication that reduces severe body inflammation, and doctors frequently prescribe infliximab for Crohn’s disease to help patients achieve long-term digestive remission.

  • Targeted inflammation relief: Infliximab works by blocking tumor necrosis factor alpha to stop chronic inflammatory signals throughout the body.
  • Effective long-term remission: Infliximab for Crohn’s disease helps heal mucosal tissue and prevents future flare-ups.
  • Accessible biosimilar options: Medications like Renflexis and Inflectra offer identical health benefits and safety standards as original biologic therapies.

Living with a chronic autoimmune condition can present daily challenges that impact your energy, physical comfort, and peace of mind. When standard oral medications fail to deliver adequate relief, specialized biologic therapies offer a proven path toward long-term healing and restored quality of life. Prescribing infliximab for Crohn’s disease gives patients a targeted treatment option that reduces deep tissue inflammation and supports steady tissue recovery.

Managing chronic health conditions requires clear medical guidance, compassionate support, and dependable treatments tailored to your unique health goals. Understanding how biologic medications function inside your body can empower you to make confident decisions regarding your ongoing health journey.

In this guide, you will learn how infliximab works, why doctors recommend it, and how biosimilar options provide safe, accessible relief.

What Is Infliximab and How Does It Work?

Before exploring specific medical conditions, it is helpful to understand how this specialized biologic therapy operates inside the human body.

Infliximab (Remicade) belongs to a class of targeted medications known as monoclonal antibodies or tumor necrosis factor (TNF) blockers. In a healthy body, TNF is a natural protein that helps the immune system manage routine infection and inflammation. However, individuals living with autoimmune disorders produce excess amounts of TNF, which leads to chronic tissue damage, persistent swelling, and ongoing pain.

Infliximab binds directly to TNF proteins to neutralize their harmful activity and interrupt inflammatory signals throughout affected tissues. By stopping these signals, the medication helps reduce swelling, relieve painful physical symptoms, and protect healthy organs from progressive damage. Patients receive this medication through intravenous infusion therapy under the careful supervision of trained healthcare professionals.

Biologic therapies like infliximab (Remicade) do not suppress the entire immune system in an uncontrolled manner. Instead, they target specific proteins responsible for driving targeted tissue swelling. This focused approach makes infliximab a powerful tool for managing complex inflammatory conditions when standard oral medications do not provide sufficient control.

Why Doctors Prescribe Infliximab for Crohn’s Disease

Crohn’s disease is a chronic inflammatory bowel condition that causes severe swelling throughout the digestive tract lining.

Gastroenterologists frequently recommend infliximab for Crohn’s disease when traditional treatments, such as oral corticosteroids or immunosuppressants, do not control flare-ups. The medication works deep within the intestinal tissue to stop persistent inflammation, relieve severe abdominal cramps, and reduce chronic diarrhea.

By calming inflammation, infliximab for Crohn’s disease helps repair damaged bowel tissue and promotes genuine mucosal healing.

Clinical studies consistently highlight the effectiveness of this biologic therapy for maintaining long-term disease remission. A landmark study published in Clinical Gastroenterology and Hepatology evaluated patient outcomes and found that 37.5% of biologic-naïve patients achieved complete endoscopic remission while 60.1% achieved systemic C-reactive protein remission during initial therapy.

These findings demonstrate that initiating infliximab for Crohn’s disease helps control active inflammation and prevents permanent structural bowel damage.

Additionally, extensive maintenance research supports the continuous use of this medication over extended periods. A major systematic review published in the Cochrane Database of Systematic Reviews confirmed that maintenance infusions of infliximab effectively maintain medically induced remission and reduce clinical relapse rates in patients with moderate-to-severe Crohn’s disease.

Regular scheduled infusions allow individuals to enjoy steady symptom relief and regain control over their daily routines.

What Other Autoimmune Conditions Does Infliximab Treat?

While gastroenterologists widely prescribe infliximab for Crohn’s disease, the FDA has approved this versatile drug for several other chronic inflammatory disorders.

  • Ulcerative colitis: This chronic condition causes painful sores and persistent inflammation along the inner lining of the large intestine.
  • Rheumatoid arthritis: Using infliximab-abda (Renflexis) for RA helps prevent joint erosion, decreases physical swelling, and protects overall joint mobility.
  • Ankylosing spondylitis: This inflammatory disease affects the spine, causing stiffness, joint pain, and reduced back flexibility.
  • Psoriatic arthritis: Individuals with joint inflammation accompanied by skin lesions experience reduced joint pain and clearer skin.
  • Plaque psoriasis: Infliximab helps clear severe, persistent skin plaques when other systemic therapies do not deliver sufficient results.

Each of these chronic conditions shares a common underlying mechanism involving overactive TNF protein activity. By neutralizing TNF proteins, infliximab calms systemic inflammation across multiple organ systems. Patients suffering from complex, multi-system inflammatory issues often experience dramatic health improvements after starting infusion therapy.

What Is Inflectra Used for and How Does It Compare to Renflexis?

As biologic science advances, biosimilar medications have become widely available to offer patients flexible and affordable treatment choices.

Infliximab-dyyb (Inflectra) is an FDA-approved biosimilar that treats the exact same conditions as original infliximab (Remicade). A biosimilar is a biologic product that is highly similar to an original reference drug in structure, safety, and clinical effectiveness. Biosimilars undergo rigorous testing by the FDA to verify that they deliver identical therapeutic results without introducing new health risks.

Similarly, healthcare providers frequently prescribe Renflexis for Crohn’s disease as a trusted biosimilar option. Choosing Renflexis for Crohn’s disease allows individuals to receive the exact same clinical benefits and mucosal healing as the originator drug. Because biosimilars contain the same active mechanism, patients can transition between reference products and biosimilars safely under medical guidance.

What to Expect During Your Infliximab Infusion Therapy

Receiving infusion therapy is a straightforward, relaxing process conducted in a comfortable clinical environment.

Before starting treatment, your healthcare provider will conduct pre-treatment health screenings to ensure complete safety. These screenings typically include a blood test for latent tuberculosis (TB) and hepatitis B, along with a review of your general health history. These safety measures protect your health and ensure your body is fully prepared to start biologic therapy.

During an infusion session, a trained nurse places a small intravenous line into your arm. The medication flows gradually into your bloodstream over a period of two hours while medical staff monitor your vital signs. Patients can relax in comfortable recliners, read, listen to music, or rest quietly throughout their treatment session.

Afterward, you can typically return to your standard daily activities without experiencing significant downtime. Most treatment schedules begin with initial loading doses at week zero, week two, and week six. Following these initial doses, maintenance infusions occur every six to eight weeks depending on your doctor’s treatment plan.

Frequently Asked Questions About Infliximab Therapy

Patients starting biologic treatments often have questions about timelines, safety guidelines, and treatment expectations.

How Long Does It Take Infliximab for Crohn’s Disease to Work?

Many patients notice initial improvements in symptoms within two to six weeks after starting their first infusion. However, achieving deep tissue healing and complete disease remission may take several months of consistent maintenance therapy. Your healthcare team will monitor your clinical symptoms, blood test results, and laboratory markers to evaluate your ongoing progress.

What Are the Primary Benefits of Infliximab for Crohn’s Disease?

The main benefits include rapid reduction of digestive inflammation, healing of the intestinal lining, and prevention of future disease flare-ups. Patients using infliximab for Crohn’s disease often experience fewer hospital visits, reduced dependence on oral corticosteroids, and significant improvements in daily energy.

Are Biosimilar Options Like Renflexis for Crohn’s Disease Effective?

Yes, biosimilars undergo rigorous comparative testing to demonstrate identical clinical efficacy and safety profiles. Choosing Renflexis for Crohn’s disease provides the exact same therapeutic strength and tissue-healing benefits as the original reference biologic product.

Where to Get Infliximab for Crohn’s Disease in Atlanta, Georgia

If you are seeking expert infusion therapy for chronic health conditions, receiving care in a compassionate setting makes a significant difference.

At GI Care Infusion, our experienced clinical team specializes in administering specialized biologic treatments for complex autoimmune disorders. Our outpatient centers focus exclusively on delivering advanced biologic infusions for individuals managing chronic conditions. Our goal is to provide a safe, soothing environment where you can receive top-tier medical care with complete confidence.

Our dedicated staff ensures your comfort through personalized care plans, flexible scheduling, and on-site medical supervision. Contact our team today at (470) 785-4616, fill out our appointment request form, or visit GI Care Infusion to learn how our specialized infusion services can support your long-term health journey.

 

Filed Under: Crohn's Disease Tagged With: gastroenterologists, Infliximab for Crohn's disease, Infliximab for Crohn's disease in Atlanta, infusion therapy, Managing chronic health conditions, Remicade, Renflexis for Crohn's disease, renflexis for RA, what is inflectra used for

Primary Sidebar

Categories

  • Avsola
  • Crohn's Disease
  • Inflectra
  • Infusion Center
  • Infusion Therapy
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Tags

abdominal pain chronic conditions crohn's disease crohn's disease treatments crohn's disease treatments near me digestive system Entyvio for Crohn's Disease entyvio infusion Entyvio Infusions infusion infusion center atlanta infusion center near me infusions for crohn's disease infusions for rheumatoid arthritis infusions for ulcerative colitis infusion therapies infusion therapy Infusion Therapy for Rheumatoid Arthritis Infusion Therapy Near Me infusion treatments infusion treatments atlanta iv infusion near me iv therapy iv therapy in atlanta iv therapy marietta ga iv therapy near me IV Therapy Near Me in Atlanta outpatient iv therapy near me Psoriasis psoriasis treatment psoriasis treatment center near me psoriasis treatment center near you Psoriasis Treatment in Atlanta psoriasis treatment near me psoriasis treatment near you psoriatic arthritis psoriatic arthritis treatment Remicade Remicade Infusion Renflexis for Crohn's disease Rheumatoid Arthritis rheumatoid arthritis treatment Stelara Ulcerative Colitis ulcerative colitis treatment

Footer

Our Locations

Atlanta, GA

Alpharetta, GA

Marietta, GA

Lawrenceville, GA

Watkinsville, GA

Request An Appointment

Home

About Us

Blog

What to Expect

Conditions

Infusions

Physician Referral

Locations

Contact Us

Request An Appointment

ADA Disclaimer

HIPAA Privacy Policy

Sitemap

Home

About Us

What to Expect

Conditions

Infusions

Physician Referral

Locations

Contact Us

Request An Appointment

ADA Disclaimer

HIPAA Privacy Policy

Sitemap

Copyright © · GI Care Infusion · All Rights Reserved

iHealthspot Medical Website Design and Medical Marketing by Hedy & Hopp.